Cargando…
A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells
BACKGROUND: The development of effective cancer vaccines still remains a challenge. Despite the crucial role of plasmacytoid dendritic cells (pDCs) in anti-tumor responses, their therapeutic potential has not yet been worked out. We explored the relevance of HLA-A*0201 matched allogeneic pDCs as vec...
Autores principales: | Aspord, Caroline, Charles, Julie, Leccia, Marie-Therese, Laurin, David, Richard, Marie-Jeanne, Chaperot, Laurence, Plumas, Joel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864288/ https://www.ncbi.nlm.nih.gov/pubmed/20454561 http://dx.doi.org/10.1371/journal.pone.0010458 |
Ejemplares similares
-
Melanoma hijacks plasmacytoid dendritic cells to promote its own progression
por: Aspord, Caroline, et al.
Publicado: (2014) -
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial
por: Charles, Julie, et al.
Publicado: (2020) -
A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients
por: Hannani, Dalil, et al.
Publicado: (2023) -
Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation
por: Veron, Philippe, et al.
Publicado: (2009) -
Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints
por: Girard, Pauline, et al.
Publicado: (2020)